Filter by

Standort

mehr »

Unternehmen

mehr »

6 Jobs gefunden

Immunic AG  •  2023-09-05
  Gräfelfing, Landkreis München, Upper Bavaria, Bavaria, DE

Hr Administrator (M/W/X)

Über uns Immunic Therapeutics ist ein dynamisches Biotechnologieunternehmen mit einem Portfolio selektiver, oral verfügbarer Immuntherapien zur…

immunic ag  •  2024-04-18
  Gräfelfing, DE

(Senior) Manager Quality Management (m/f/x)

Your mission The Senior Manager of Quality Management will be instrumental in maintaining and enhancing our quality management systems. You will collaborate with cross-functional teams to ensure compliance with GxP and other regulatory standards, contributing …

immunic ag  •  2024-04-17
  Gräfelfing, DE

Global Clinical Operations Program Lead (COPL) (m/f/x)

Your mission We are currently seeking an experienced global Clinical Operations Program Lead (COPL) in our Clinical Development Operations team. As a COPL at Immunic, you will be responsible for the strategic planning, execution, and leadership of a portfolio …

immunic ag  •  2024-04-16
  Gräfelfing, DE

(Regional) Clinical Study Lead (CSL) (m/f/x)

Your mission Immunic is at the forefront of biotechnological research, dedicated to making a significant impact on global health. We are currently seeking a skilled Clinical Study Lead in our Clinical Development Operations team to oversee and manage the day-t…

immunic ag  •  2024-04-18
  Gräfelfing, DE

Team Assistant Clinical Development Operations (m/f/x)

Your mission Immunic is on a mission to drive innovation in the biotechnology sector, focusing on developing treatments that significantly improve health outcomes. Join us as a Team Assistant Clinical Development Operations and play a pivotal role in coordinat…

Immunic AG  •  2024-04-01
  82166 Gräfelfing, DE

Program Head IMU-838 (Vidofludimus Calcium) (m/f/x)

Immunic Therapeutics is a dynamic biotechnology company with a pipeline of selective, orally available immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Currently, three small molecule product candidates are in various sta…